Jeeva Clinical Trials Inc.

Founded by Dr. Harsha Rajasimha after his deeply personal, family, and professional experiences, Jeeva's mission to "Modernize Clinical Research with Human-Centric Software and turnkey CRO solutions" propels their innovative clinical trial management platform with AI and workflow automation under one bundled subscription. Jeeva empowers global biopharmaceutical, medical device, and nutraceutical sponsors, simplifying patient engagement and evidence generation, achieving 70% greater efficiency in research. Trusted by prestigious organizations like Frantz Viral Therapeutics and George Mason University, their technology supports diverse study designs, from traditional to fully decentralized models, across disease areas including oncology and rare diseases. With empathy and determination, team Jeeva has developed a patient-centric and unified platform that enables sponsors to conduct clinical trials more effectively, breaking down barriers and fostering a globally inclusive and diverse participant pool. This includes facilitating remote participation. Powered by AI and automation, Jeeva is transforming the healthcare and life sciences industry, one clinical study at a time. Discover more about how Jeeva is reimagining the future of clinical trials at https://jeevatrials.com/. The AI-driven Jeeva platform automates and centralizes the schedule of visits and protocol configuration that maps to modules in the platform. Modules include eConsent, ePRO/eCOA/EDC, TeleVisits/VideoVisits, Adverse event capture with MedDRA coding, and patient engagement portal with SMS/email/audio/video communications/reminders/notifications.